TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a ...

Diagnostic devices used for blood clotting assessment have evolved from basic timing tools into complex analytical systems. Worldwide demand for these critical medical devices continues to grow ...

The global coagulation analyzer market is on a robust growth trajectory, with its valuation projected to reach USD 9.2 billion by 2034, up from an estimated USD 4.8 billion in 2024. The market is set ...